CL2013001774A1 - Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates. - Google Patents

Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates.

Info

Publication number
CL2013001774A1
CL2013001774A1 CL2013001774A CL2013001774A CL2013001774A1 CL 2013001774 A1 CL2013001774 A1 CL 2013001774A1 CL 2013001774 A CL2013001774 A CL 2013001774A CL 2013001774 A CL2013001774 A CL 2013001774A CL 2013001774 A1 CL2013001774 A1 CL 2013001774A1
Authority
CL
Chile
Prior art keywords
formulation
alpinone
immunostimulant
vertebrates
dimethyl sulfoxide
Prior art date
Application number
CL2013001774A
Other languages
Spanish (es)
Inventor
Modak Canobra Brenda
Imarai Bahamonde Monica
Valenzuela Montenegro Beatriz
Original Assignee
Univ Santiago Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Santiago Chile filed Critical Univ Santiago Chile
Priority to CL2013001774A priority Critical patent/CL2013001774A1/en
Priority to CA2854513A priority patent/CA2854513A1/en
Priority to NO20140763A priority patent/NO343949B1/en
Priority to GB1410879.9A priority patent/GB2519828B/en
Publication of CL2013001774A1 publication Critical patent/CL2013001774A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL2013001774A 2013-06-18 2013-06-18 Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates. CL2013001774A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CL2013001774A CL2013001774A1 (en) 2013-06-18 2013-06-18 Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates.
CA2854513A CA2854513A1 (en) 2013-06-18 2014-06-17 Formulation with immuno-stimulant/adjuvant activity
NO20140763A NO343949B1 (en) 2013-06-18 2014-06-18 Formulation with immunostimulant / adjuvant activity and use as vaccines for vertebrates
GB1410879.9A GB2519828B (en) 2013-06-18 2014-06-18 Formulation with immuno-stimulant/adjuvant activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2013001774A CL2013001774A1 (en) 2013-06-18 2013-06-18 Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates.

Publications (1)

Publication Number Publication Date
CL2013001774A1 true CL2013001774A1 (en) 2014-08-01

Family

ID=51266802

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013001774A CL2013001774A1 (en) 2013-06-18 2013-06-18 Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates.

Country Status (4)

Country Link
CA (1) CA2854513A1 (en)
CL (1) CL2013001774A1 (en)
GB (1) GB2519828B (en)
NO (1) NO343949B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2013001774A1 (en) * 2013-06-18 2014-08-01 Univ Santiago Chile Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates.
CN114748617B (en) * 2022-03-24 2024-04-16 华南农业大学 Subunit vaccine of largemouth black bass iridovirus, and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010072957A (en) * 1998-08-24 2001-07-31 추후보정 Activation and protection of t-cells(cd4+ and cd8+) using an h2 receptor agonist and other t-cell activating agents
CN105056229A (en) * 2009-01-05 2015-11-18 埃皮托吉尼西斯股份有限公司 Adjuvant compositions and methods of use
CA2839507A1 (en) * 2011-06-24 2012-12-27 Epitogenesis Inc. Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
CL2013001774A1 (en) * 2013-06-18 2014-08-01 Univ Santiago Chile Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates.

Also Published As

Publication number Publication date
NO20140763A1 (en) 2014-12-19
NO343949B1 (en) 2019-07-22
GB2519828A (en) 2015-05-06
CA2854513A1 (en) 2014-12-18
GB2519828B (en) 2018-06-20
GB201410879D0 (en) 2014-07-30

Similar Documents

Publication Publication Date Title
CR20160141A (en) ANTI-PDL1 ANTIBODY FORMULATIONS
BR112016000489A2 (en) compound, pharmaceutical composition comprising it, use of the composition and methods for making compounds
BR112015015758A2 (en) solid dispersion, solid formulation, method of preparing a solid dispersion, pharmaceutical preparation and use of a solid dispersion
CL2015003440A1 (en) Compositions of arni against tmprss6 and methods for use
EP3041504A4 (en) Thermally stable vaccine formulations and microneedles
BR112016030968A2 (en) pridopidine analogues, preparation and use of these
CL2014001930A1 (en) Pharmaceutical formulation comprising an angiopoietin 2 (anti-ang2) antibody.
ECSP16059106A (en) LINACHLOTIDE DELAYED RELEASE COMPOSITIONS
BR112014031262A2 (en) innovative biocatalyst compositions and processes for use.
BR112015031979A2 (en) letermovir, solid oral pharmaceutical formulation, use of a solid oral pharmaceutical formulation, and process for preparing letermovir.
BR112015022167A2 (en) sample preparation devices, systems and methods
DK2966079T3 (en) PYRIDOPYRIMIDINE OR PYRIDOPYRIMIDINE COMPOUND, MANUFACTURING PROCEDURE, PHARMACEUTICAL COMPOSITION AND USE
BR112013015942A2 (en) pump devices and methods for using them.
BR112015016548A2 (en) polymyxins, compositions, preparation methods and methods of use
BR112015022347A2 (en) vaccination composition, method for producing a vaccination composition and use of composition
CL2015001085A1 (en) Prolonged release formulation comprising oprozomib and also one or more pharmaceutically acceptable polymers; method of preparation of the formulation; method to treat cancer.
BR112015000152A2 (en) buffer for the days between menstruations
CL2016001153A1 (en) Fish vaccine
DK3054972T3 (en) VACCINES WITH INTERLEUKIN-33 AS AN ADJUSTMENT
CL2015002110A1 (en) Porcine parvovirus 5b, methods of use and vaccine
BR112014031513A2 (en) concentrated food composition, process for preparing a concentrated food composition and use of the composition
CL2016000998A1 (en) Herbal composition, procedure for its preparation and use
CL2016001369A1 (en) Procedure for the preparation of an oil-in-water emulsifier
BR112013023575A2 (en) “octahydrothienoquinoline derivative, pharmaceutical composition comprising the derivative, and use thereof”
BR112015021722A2 (en) composition for use in the treatment of polycystic ovary syndrome